chrX-53193039-C-T
Variant summary
Our verdict is Benign. Variant got -10 ACMG points: 0P and 10B. BP4_StrongBP6BP7BS2
The NM_004187.5(KDM5C):c.4611G>A(p.Ser1537=) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000015 in 1,196,479 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 2 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_004187.5 synonymous
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -10 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
KDM5C | NM_004187.5 | c.4611G>A | p.Ser1537= | synonymous_variant | 26/26 | ENST00000375401.8 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
KDM5C | ENST00000375401.8 | c.4611G>A | p.Ser1537= | synonymous_variant | 26/26 | 1 | NM_004187.5 | P5 |
Frequencies
GnomAD3 genomes AF: 0.0000823 AC: 9AN: 109394Hom.: 0 Cov.: 20 AF XY: 0.00 AC XY: 0AN XY: 31724
GnomAD3 exomes AF: 0.0000121 AC: 2AN: 165679Hom.: 0 AF XY: 0.0000188 AC XY: 1AN XY: 53239
GnomAD4 exome AF: 0.00000828 AC: 9AN: 1087085Hom.: 0 Cov.: 33 AF XY: 0.00000564 AC XY: 2AN XY: 354581
GnomAD4 genome AF: 0.0000823 AC: 9AN: 109394Hom.: 0 Cov.: 20 AF XY: 0.00 AC XY: 0AN XY: 31724
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Genetic Services Laboratory, University of Chicago | Jan 21, 2015 | - - |
Spastic paraplegia Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | May 05, 2022 | - - |
Inborn genetic diseases Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Jul 25, 2014 | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at